93 related articles for article (PubMed ID: 32783707)
1. Critical Drugs for Critical Care: Protecting the US Pharmaceutical Supply in a Time of Crisis.
Socal MP; Sharfstein JM; Greene JA
Am J Public Health; 2020 Sep; 110(9):1346-1347. PubMed ID: 32783707
[No Abstract] [Full Text] [Related]
2. China's Coronavirus-Induced Paralysis Threatens U.S. Drug Supply Chain.
Miller HI; Cohrssen JJ
Mo Med; 2020; 117(2):86-88. PubMed ID: 32308220
[No Abstract] [Full Text] [Related]
3. COVID-19 and Drug Shortages: A Call to Action.
Shuman AG; Fox ER; Unguru Y
J Manag Care Spec Pharm; 2020 Aug; 26(8):945-947. PubMed ID: 32715960
[TBL] [Abstract][Full Text] [Related]
4. The coronavirus outbreak could make it quicker and easier to trial drugs.
Ledford H
Nature; 2020 Jun; 582(7811):172. PubMed ID: 32504019
[No Abstract] [Full Text] [Related]
5. Drug Shortages and the Defense Production Act.
Raunig BL; Kesselheim AS; Darrow JJ
Am J Public Health; 2020 Oct; 110(10):1504-1505. PubMed ID: 32903085
[No Abstract] [Full Text] [Related]
6. Medication Shortages During the COVID-19 Crisis: What We Must Do.
Choo EK; Rajkumar SV
Mayo Clin Proc; 2020 Jun; 95(6):1112-1115. PubMed ID: 32312491
[No Abstract] [Full Text] [Related]
7. Dozens of coronavirus drugs are in development - what happens next?
Ledford H
Nature; 2020 May; 581(7808):247-248. PubMed ID: 32409766
[No Abstract] [Full Text] [Related]
8. All together to Fight COVID-19.
Momtazmanesh S; Ochs HD; Uddin LQ; Perc M; Routes JM; Vieira DN; Al-Herz W; Baris S; Prando C; Rosivall L; Abdul Latiff AH; Ulrichs T; Roudenok V; Aldave Becerra JC; Salunke DB; Goudouris E; Condino-Neto A; Stashchak A; Kryvenko O; Stashchak M; Bondarenko A; Rezaei N
Am J Trop Med Hyg; 2020 Jun; 102(6):1181-1183. PubMed ID: 32323644
[TBL] [Abstract][Full Text] [Related]
9. The healthcare and pharmaceutical vulnerability emerging from the new Coronavirus outbreak.
Leonardi Vinci D; Polidori C; Polidori P
Eur J Hosp Pharm; 2020 May; 27(3):129-130. PubMed ID: 32419930
[No Abstract] [Full Text] [Related]
10. The consequence of COVID-19 on the global supply of medical products: Why Indian generics matter for the world?
Guerin PJ; Singh-Phulgenda S; Strub-Wourgaft N
F1000Res; 2020; 9():225. PubMed ID: 32566139
[TBL] [Abstract][Full Text] [Related]
11. How to help the free market fight coronavirus.
Burley SK
Nature; 2020 Apr; 580(7802):167. PubMed ID: 32210376
[No Abstract] [Full Text] [Related]
12. The case for compulsory licensing during COVID-19.
Wong H
J Glob Health; 2020 Jun; 10(1):010358. PubMed ID: 32509289
[No Abstract] [Full Text] [Related]
13. National drug shortages worsen during COVID-19 crisis: Proposal for a comprehensive model to monitor and address critical drug shortages.
Piatek OI; Ning JC; Touchette DR
Am J Health Syst Pharm; 2020 Oct; 77(21):1778-1785. PubMed ID: 32716030
[TBL] [Abstract][Full Text] [Related]
14. Community-Based Epidemic Prevention in Taiwan: Combating the Coronavirus Disease-2019 Crisis.
Lo HA; Huang JJ; Chen CC; Tsai D; Chou FH; Shieh V
Disaster Med Public Health Prep; 2020 Jun; 14(3):e15-e16. PubMed ID: 32375919
[No Abstract] [Full Text] [Related]
15. The need to implement non-industry COVID-19 clinical trials in non-high-income countries.
Dal-Ré R; Carcas AJ; Sreeharan N
J Glob Health; 2020 Jun; 10(1):010351. PubMed ID: 32509284
[No Abstract] [Full Text] [Related]
16. Indian pharma threatened by COVID-19 shutdowns in China.
Chatterjee P
Lancet; 2020 Feb; 395(10225):675. PubMed ID: 32113494
[No Abstract] [Full Text] [Related]
17. Therapeutic alternatives and strategies for drug conservation in the intensive care unit during times of drug shortage: a report of the Ontario COVID-19 ICU Drug Task Force.
Kanji S; Burry L; Williamson D; Pittman M; Dubinsky S; Patel D; Natarajan S; MacLean R; Huh JH; Scales DC; Neilipovitz D;
Can J Anaesth; 2020 Oct; 67(10):1405-1416. PubMed ID: 32458267
[TBL] [Abstract][Full Text] [Related]
18. Applications of 3D Printing Technology to Address COVID-19-Related Supply Shortages.
Ishack S; Lipner SR
Am J Med; 2020 Jul; 133(7):771-773. PubMed ID: 32330492
[No Abstract] [Full Text] [Related]
19. Adjuvant corticosteroid therapy for critically ill patients with COVID-19.
Lu X; Chen T; Wang Y; Wang J; Yan F
Crit Care; 2020 May; 24(1):241. PubMed ID: 32430057
[No Abstract] [Full Text] [Related]
20. Controls to Minimize Disruption of the Pharmaceutical Supply Chain During the COVID-19 Pandemic.
Cundell T; Guilfoyle D; Kreil TR; Sawant A
PDA J Pharm Sci Technol; 2020; 74(4):468-494. PubMed ID: 32467176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
